223 related articles for article (PubMed ID: 15024079)
21. A positive role for the PP2A catalytic subunit in Wnt signal transduction.
Ratcliffe MJ; Itoh K; Sokol SY
J Biol Chem; 2000 Nov; 275(46):35680-3. PubMed ID: 11007767
[TBL] [Abstract][Full Text] [Related]
22. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
23. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
24. Frizzled receptor dimerization is sufficient to activate the Wnt/beta-catenin pathway.
Carron C; Pascal A; Djiane A; Boucaut JC; Shi DL; Umbhauer M
J Cell Sci; 2003 Jun; 116(Pt 12):2541-50. PubMed ID: 12734397
[TBL] [Abstract][Full Text] [Related]
25. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2.
Hussein SM; Duff EK; Sirard C
J Biol Chem; 2003 Dec; 278(49):48805-14. PubMed ID: 14551209
[TBL] [Abstract][Full Text] [Related]
26. The maternal Xenopus beta-catenin signaling pathway, activated by frizzled homologs, induces goosecoid in a cell non-autonomous manner.
Brown JD; Hallagan SE; McGrew LL; Miller JR; Moon RT
Dev Growth Differ; 2000 Aug; 42(4):347-57. PubMed ID: 10969734
[TBL] [Abstract][Full Text] [Related]
27. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.
You L; He B; Xu Z; Uematsu K; Mazieres J; Fujii N; Mikami I; Reguart N; McIntosh JK; Kashani-Sabet M; McCormick F; Jablons DM
Cancer Res; 2004 Aug; 64(15):5385-9. PubMed ID: 15289346
[TBL] [Abstract][Full Text] [Related]
28. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the Wnt signaling pathway by disabled-2 (Dab2).
Hocevar BA; Mou F; Rennolds JL; Morris SM; Cooper JA; Howe PH
EMBO J; 2003 Jun; 22(12):3084-94. PubMed ID: 12805222
[TBL] [Abstract][Full Text] [Related]
30. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter.
Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA
J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254
[TBL] [Abstract][Full Text] [Related]
31. Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway.
Baek SH; Kioussi C; Briata P; Wang D; Nguyen HD; Ohgi KA; Glass CK; Wynshaw-Boris A; Rose DW; Rosenfeld MG
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3245-50. PubMed ID: 12629224
[TBL] [Abstract][Full Text] [Related]
32. Casein kinase Iepsilon modulates the signaling specificities of dishevelled.
Cong F; Schweizer L; Varmus H
Mol Cell Biol; 2004 Mar; 24(5):2000-11. PubMed ID: 14966280
[TBL] [Abstract][Full Text] [Related]
33. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
[TBL] [Abstract][Full Text] [Related]
34. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
35. Identification of the LIM protein FHL2 as a coactivator of beta-catenin.
Wei Y; Renard CA; Labalette C; Wu Y; Lévy L; Neuveut C; Prieur X; Flajolet M; Prigent S; Buendia MA
J Biol Chem; 2003 Feb; 278(7):5188-94. PubMed ID: 12466281
[TBL] [Abstract][Full Text] [Related]
36. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.
Bosserhoff AK; Ellmann L; Kuphal S
Exp Dermatol; 2011 May; 20(5):435-40. PubMed ID: 21496114
[TBL] [Abstract][Full Text] [Related]
37. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells.
Lyons JP; Mueller UW; Ji H; Everett C; Fang X; Hsieh JC; Barth AM; McCrea PD
Exp Cell Res; 2004 Aug; 298(2):369-87. PubMed ID: 15265686
[TBL] [Abstract][Full Text] [Related]
38. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
39. Regulation of dharma/bozozok by the Wnt pathway.
Ryu SL; Fujii R; Yamanaka Y; Shimizu T; Yabe T; Hirata T; Hibi M; Hirano T
Dev Biol; 2001 Mar; 231(2):397-409. PubMed ID: 11237468
[TBL] [Abstract][Full Text] [Related]
40. The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis.
Vleminckx K; Kemler R; Hecht A
Mech Dev; 1999 Mar; 81(1-2):65-74. PubMed ID: 10330485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
